Skip to main content
. 2015 Jul 8;5:11961. doi: 10.1038/srep11961

Table 1. Characteristics of included studies.

Author Year Study type Ethnicity (Country) Cancer type Source of control Genotyping Matching Y/N Sample size Case/Control Qualitya control PHWE
Peng[15] 2014 Case-control Asian (China) ESCC Population Sequenom N 50/50 N NA
Peng[15] 2014 Case-control Asian (China) GCA Population Sequenom N 50/50 N NA
Piao [16] 2014 Case-control Asian (Korea) ESCC Population HRM Y 321/1700 Y 0.724
Gu [17] 2012 Case-control Asian (China) ESCC Hospital MassArray Y 379/375 Y 0.648
Wei [18] 2012 Case-control Asian (China) ESCC Population PCR-RFLP Y 240/198 Y 0.354
Dura [19] 2012 Case-control Caucasian (Netherland) ESCC Population Real-Time PCR Y 344/580 N 0.267
Zhou [20] 2012 Case-control Asian (China) ESCC Population Chips Y 4722/4732 Y 0.639
Ren [21] 2011 Case-control Asian (China) GCA Population Chips Y 2748/10136 Y 0.407
Shang [22] 2011 Case-control Asian (China) ESCC Population MALDI-TOF-MS Y 190/211 N 0.336
Zhang [23] 2011 Case-control Asian (China) GCA Population TaqMan Y 1668/1841 Y 0.284
Wang [10] 2010 GWAS Asian (China) ESCC Population Chips Y 9053/13283 Y NA
Wang [10] 2010 GWAS Asian (China) GCA Population Chips Y 2766/11013 Y NA

ESCC, Esophageal squamous cell carcinoma; GCA, Gastric cardia adenocarcinoma; NA: Not applicable for the lack of C allele;

HRM, High-resolution melting; MALDI-TOF-MS, Matrix-Assisted Laser Desorption/Ionization Time of Flight Mass Spectrometry;

aQuality control was conducted when sample of cases and controls was genotyped.